Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-02-25 @ 9:44 PM
Study NCT ID:
NCT00780494
Status:
COMPLETED
Last Update Posted:
2025-01-14
First Post:
2008-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2017-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-23
First Submit QC Date:
None
Study First Post Date:
2008-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-31
Results First Submit QC Date:
None
Results First Post Date:
2019-09-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-20
Last Update Post Date:
2025-01-14
Last Update Post Date Type:
ACTUAL